Understanding Fibroadenoma: This resource provides information on Fibroadenoma, also known as Breast Fibroadenoma and Benign Breast Tumor. Learn about diagnosis, clinical documentation, and medical coding for Fibroadenoma (F) including relevant healthcare and ICD codes. Find details helpful for physicians, nurses, and other healthcare professionals.
Also known as
Benign mammary dysplasias
Covers noncancerous breast changes like fibroadenoma.
Benign neoplasm of breast
Includes various noncancerous breast growths.
Abnormal findings, mammogram
May be used for mammographic findings suggestive of fibroadenoma.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the fibroadenoma of the breast?
Yes
Is it Phyllodes tumor?
No
Location of fibroadenoma?
When to use each related code
| Description |
|---|
| Common benign breast tumor, solid but movable. |
| Fluid-filled breast cyst, often tender. |
| Overgrowth of normal breast tissue, often painful. |
Missing or incorrect laterality (right, left, bilateral) for fibroadenoma impacts reimbursement and data accuracy. Code N60.1 requires laterality.
Documenting 'breast mass' instead of 'fibroadenoma' lacks specificity. Accurate coding requires precise clinical documentation for N60.1.
Distinct coding (N60.1x) is needed for multiple fibroadenomas to reflect complexity. Each site requires separate coding and documentation.
Q: How can I differentiate a fibroadenoma from other breast masses during a clinical breast exam and determine when further diagnostic imaging is necessary?
A: Differentiating a fibroadenoma from other breast masses clinically can be challenging. Fibroadenomas typically present as firm, rubbery, mobile, non-tender nodules with well-defined borders. However, other conditions like cysts, phyllodes tumors, and even early-stage breast cancers can share similar characteristics. A thorough clinical breast exam, including assessment of size, shape, mobility, and tenderness, is crucial. If any uncertainty exists regarding the diagnosis, further diagnostic imaging is warranted. Ultrasound is often the first-line imaging modality for evaluating palpable breast masses, particularly in younger women. Mammography may also be employed, especially in older patients or if ultrasound findings are inconclusive. Explore how a combination of clinical assessment and targeted imaging can improve diagnostic accuracy for fibroadenomas and other breast masses. Consider implementing standardized diagnostic pathways for breast masses in your practice to ensure optimal patient care.
Q: What are the best management strategies for fibroadenomas in adolescent girls and young women, considering their potential for growth and regression?
A: Managing fibroadenomas in adolescents and young women often involves a conservative approach. Many fibroadenomas, especially in this age group, are small, asymptomatic, and may even regress spontaneously over time. Close clinical follow-up with repeat breast exams and periodic imaging (e.g., ultrasound) is essential to monitor for changes in size or other characteristics. Short-term follow-up imaging can be helpful to confirm stability. If the fibroadenoma is large, rapidly growing, causing symptoms, or raises significant diagnostic concern, further intervention may be necessary. This could include a core needle biopsy to confirm the diagnosis or, less commonly, surgical excision. Learn more about the natural history of fibroadenomas and consider implementing evidence-based clinical guidelines for their management in younger patients.
Patient presents with a palpable breast lump, prompting evaluation for fibroadenoma. The patient reports finding a discrete, mobile, non-tender mass in the [right/left] breast. Physical examination confirms the presence of a firm, rubbery, well-circumscribed nodule approximately [size] cm in diameter located in the [location] quadrant of the breast. No skin changes, nipple discharge, or axillary lymphadenopathy are noted. The patient denies any pain, fever, or other systemic symptoms. Ultrasound imaging of the breast was performed and revealed a solid, ovoid mass with smooth margins, consistent with the clinical suspicion of a breast fibroadenoma. Differential diagnoses include other benign breast conditions such as cysts, lipomas, and phyllodes tumors. Malignant processes, such as breast cancer, were considered less likely given the clinical and imaging findings. Based on the patient's age, clinical presentation, and imaging results, a diagnosis of fibroadenoma is made. Management options, including watchful waiting with serial imaging, fine-needle aspiration biopsy for definitive diagnosis, or surgical excision, were discussed with the patient. The patient elected for [chosen management option]. Patient education was provided regarding breast self-examination and follow-up care. Return visit scheduled in [timeframe] for [reason]. ICD-10 code D24.0 (benign neoplasm of breast) is applicable.